Cardioprotective Vaccination Effects: Association Between Vaccination Knowledge, Risk Perception, and Vaccination Intention in Older Patients with Pre-Existing Conditions.
- 1Institute of Infectious Diseases and Infection Control, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.
- 2Center for Sepsis Control and Care, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.
- 3Department of Geriatrics, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.
Abstract
Background/objectives
Cardiovascular diseases (CVDs) remain a major contributor to morbidity, mortality, and healthcare costs worldwide. Acute respiratory infections such as influenza and pneumococcal disease can precipitate severe cardiovascular events, while vaccination against these pathogens offers both infection-related and cardioprotective benefits. The extent to which individuals are aware of these associations and how such knowledge shapes risk perception and vaccination intention remains unclear.Methods
In a cross-sectional survey conducted between July and September 2025 in Germany, 101 geriatric patients and individuals with pre-existing cardiovascular conditions were assessed regarding their knowledge of infection-related cardiovascular risks and cardioprotective vaccination benefits, risk perception, and vaccination intention.Results
While 64.4% of participants recognized the increased cardiovascular risk associated with acute respiratory infections, only 40.6% were aware of the cardioprotective benefits of vaccination. Knowledge of infection-related cardiovascular risk was linked to higher perceived disease severity, whereas awareness of cardioprotective vaccination effects was associated with greater perceived usefulness of influenza and pneumococcal vaccinations. Crucially, only knowledge of cardioprotective benefits (by(flu) = 0.46, by(pneu) = 0.45), but not knowledge of infection-related cardiovascular risk (by(flu) = 0.08, by(pneu) = 0.34) was significantly associated with higher vaccination intention.Conclusions
These findings highlight substantial knowledge gaps regarding the cardioprotective benefits of influenza and pneumococcal vaccination. These findings support further evaluation of whether communication emphasizing potential cardioprotective benefits can influence vaccination intentions and subsequent vaccine uptake in prospective or interventional studies.
Related
- Editorial: Measuring vaccination perception, confidence, and uptake: advancing instrument development and validation
- Does COVID‐19 Vaccination Protect Against Post‐COVID Cardiovascular Conditions?
- Three-year longitudinal safety surveillance following COVID-19 vaccination in individuals with underlying medical conditions
- Knowledge, Perception, and Intention to Promote Malaria Vaccination Among Students in Southwestern Nigeria: A Cross-Sectional Study.
- Calendar-Period Variation in the Association Between Documented Complete Rotavirus Vaccination and Laboratory-Confirmed Gastroenteritis: An 11-Year Test-Negative Study
BibTeX
@article{born2026cardioprotective,
title = {{Cardioprotective Vaccination Effects: Association Between Vaccination Knowledge, Risk Perception, and Vaccination Intention in Older Patients with Pre-Existing Conditions.}},
author = {Sebastian Born and Carl Zimmermann and Norman Rose and Mathias W Pletz and Konstantin G Heimrich and Carolin Fleischmann-Struzek},
journal = {Vaccines},
year = {2026},
month = oct,
doi = {10.3390/vaccines14100901},
url = {https://europepmc.org/article/MED/42931430},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cardioprotective Vaccination Effects: Association Between Vaccination Knowledge, Risk Perception, and Vaccination Intention in Older Patients with Pre-Existing Conditions.
AU - Sebastian Born
AU - Carl Zimmermann
AU - Norman Rose
AU - Mathias W Pletz
AU - Konstantin G Heimrich
AU - Carolin Fleischmann-Struzek
PY - 2026
DA - 2026/10/14
JO - Vaccines
DO - 10.3390/vaccines14100901
UR - https://europepmc.org/article/MED/42931430
AB - Background/objectives Cardiovascular diseases (CVDs) remain a major contributor to morbidity, mortality, and healthcare costs worldwide. Acute respiratory infections such as influenza and pneumococcal disease can precipitate severe cardiovascular events, while vaccination against these pathogens offers both infection-related and cardioprotective benefits. The extent to which individuals are aware of these associations and how such knowledge shapes risk perception and vaccination intention remains unclear.Methods In a cross-sectional survey conducted between July and September 2025 in Germany, 101 geriatric patients and individuals with pre-existing cardiovascular conditions were assessed regarding their knowledge of infection-related cardiovascular risks and cardioprotective vaccination benefits, risk perception, and vaccination intention.Results While 64.4% of participants recognized the increased cardiovascular risk associated with acute respiratory infections, only 40.6% were aware of the cardioprotective benefits of vaccination. Knowledge of infection-related cardiovascular risk was linked to higher perceived disease severity, whereas awareness of cardioprotective vaccination effects was associated with greater perceived usefulness of influenza and pneumococcal vaccinations. Crucially, only knowledge of cardioprotective benefits (by(flu) = 0.46, by(pneu) = 0.45), but not knowledge of infection-related cardiovascular risk (by(flu) = 0.08, by(pneu) = 0.34) was significantly associated with higher vaccination intention.Conclusions These findings highlight substantial knowledge gaps regarding the cardioprotective benefits of influenza and pneumococcal vaccination. These findings support further evaluation of whether communication emphasizing potential cardioprotective benefits can influence vaccination intentions and subsequent vaccine uptake in prospective or interventional studies.
SN - 2076-393X
ER -